Bio­gen touts glimpses of ef­fi­ca­cy in ear­ly study of tau-low­er­ing drug

An ex­per­i­men­tal ge­net­ic med­i­cine de­signed to short-cir­cuit the pro­duc­tion of the Alzheimer’s-linked pro­tein tau showed signs of slow­ing cog­ni­tive de­cline in a small study from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER